● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

PANACEABIO

BSE
Panacea Biotec Limited
Healthcare· Pharmaceuticals & Biotechnology· INE922B01023· Scrip: 531349
ENहिन्दीગુજરાતીमराठी
547.65
60.80 (+0.00%)
2026-06-10
BSE
547.65
60.80
+0.00%
31537443249155006-2308-1410-1012-0502-0204-0206-10
228 trading days · 1Y period
TODAY (BSE)
Open596.95
High596.95
Low547.65
Prev Close608.45
Volume1.53L
Value₹8.7Cr
L: 547.65H: 596.95
Info
Face Value₹1
Listed1996-04-17
ISININE922B01023
SeriesB
BSE Scrip531349

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr41 Cr82 Cr123 Cr163 Cr22-1223-0323-0923-1224-0324-0624-0924-123.2-2.1-1.4-0.4-0.2-2.30.80.7
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31163 Cr166 Cr14 Cr4 Cr4 Cr0.74
2024-09-30147 Cr150 Cr14 Cr5 Cr5 Cr0.77
2024-06-3057 Cr76 Cr-10 Cr-15 Cr-14 Cr-2.25
2024-03-31136 Cr152 Cr7 Cr-2 Cr-2 Cr-0.23
2023-12-31151 Cr161 Cr9 Cr-2 Cr-2 Cr-0.37
2023-09-30143 Cr157 Cr3 Cr-8 Cr-8 Cr-1.35
2023-03-31129 Cr145 Cr60 Cr18 Cr-13 Cr-2.07
2022-12-31115 Cr134 Cr36 Cr22 Cr19 Cr3.16

Shareholding Pattern

CURRENT2026-03-31
72.5%PROMOTER
Promoter72.5%
FII1.6%
DII2.0%
Public27.5%
PROMOTER HOLDING TREND
73.5%24-0672.9%24-0972.5%24-1272.5%25-0372.5%25-0972.5%25-1272.5%26-03

Corporate Actions

Ex-DateTypePurpose
2024-09-19OtherAnnual General Meeting
2023-09-21OtherAnnual General Meeting
2022-09-19OtherAnnual General Meeting
2021-09-16Other Annual General Meeting
2020-12-15Other Annual General Meeting
2020-09-21Demerger Demerger
2019-09-19Other Annual General Meeting
2018-09-19Other Annual General Meeting
2017-09-18Other Annual General Meeting
2016-09-22Other Annual General Meeting
2015-09-22Other Annual General Meeting
2014-09-17OtherAnnual General Meeting
2013-09-17OtherAnnual General Meeting
2012-09-20OtherAnnual General Meeting
2011-09-19DividendAnnual General Meeting And Dividend Re.0.75 Per Share
2010-09-16DividendAnnual General Meeting And Dividend Re.0.25 Per Share
2009-09-18OtherAnnual General Meeting
2008-09-19DividendAgm/Dividend - 100%
2007-09-21DividendAgm/Dividend-100%
2006-09-22DividendAgm/Dividend-100%

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-10595.00595.00547.00547.0019.22L
2026-06-03426.00437.50423.70433.601.42L
2026-05-27425.10436.75407.05413.152.19L
2026-05-26420.00439.20420.00424.051.48L
2026-05-25422.95433.45416.85419.051.82L
2026-05-22424.35427.70415.25418.5572,626
2026-05-21421.85432.00417.35424.301.89L
2026-05-20412.95423.65401.05418.351.55L
2026-05-19409.90427.00408.20416.403.03L
2026-05-18384.50412.50365.55406.504.42L
2026-05-15384.75390.55381.00386.4593,092
2026-05-14390.90391.40382.00383.7571,855
2026-05-13367.45403.00364.00391.252.62L
2026-05-12380.70384.20363.50365.551.18L
2026-05-11382.00389.95375.90380.6096,261
2026-05-08404.80405.80385.00388.7592,398
2026-05-07399.90414.50399.90403.751.90L
2026-05-06372.70407.45368.40398.655.21L
2026-05-05373.00379.75368.00370.7068,830
2026-05-04360.20378.70360.20373.201.20L
2026-04-30376.00376.00358.70361.0554,240
2026-04-29378.00384.00368.00370.7598,202
2026-04-28363.55385.00363.55377.001.73L
2026-04-27365.35375.20364.00368.851.07L
2026-04-24352.15373.00347.00368.551.77L
2026-04-23358.35369.25352.30356.501.29L
2026-04-22338.00374.25332.00363.805.62L
2026-04-21340.80346.85337.35338.1580,456
2026-04-20355.00360.50338.05341.601.33L
2026-04-17346.60362.00346.60358.751.51L

Frequently Asked Questions

About

Panacea Biotec Limited is a leading Indian pharmaceutical and biotechnology company specializing in the research, development, manufacturing, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products. Known for its focus on areas like oncology and organ transplant medicines, the company is one of India's three largest biotech firms and has a strong presence in both domestic and international markets.

BOARD OF DIRECTORS
Ankesh Jain
Whole-time Director
Bhupinder Singh
Independent Director
Manjula Upadhyay
Independent Director
DEPARTED
Mukul Gupta
Independent Director
DEPARTED
Narotam Kumar Juneja
Independent Director
DEPARTED
Rajesh Jain
Independent Director
DEPARTED